CN Stock MarketDetailed Quotes
600866 Star Lake Bioscience
- 6.87
- +0.09+1.33%
Market Closed Dec 3 15:00 CST
11.41BMarket Cap13.19P/E (TTM)
6.93High6.70Low372.54KlotVolume6.78Open6.78Pre Close254.62MTurnover3.36%Turnover Ratio16.84P/E (Static)1.66BShares8.4052wk High1.50P/B7.62BFloat Cap2.9752wk Low7.46Limit Up1.11BShs Float16.62Historical High6.10Limit Down3.39%Amplitude0.47Historical Low0.38Dividend TTM6.83Avg Price176.46KlotAsk5.53%Div YieldTTM100Lot Size192.88KlotBid
Star Lake Bioscience Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 0.48%12.79B | 2.66%8.49B | 0.87%4.2B | -0.64%17.37B | -1.12%12.73B | -6.29%8.27B | -0.18%4.16B | 329.51%17.49B | 1,397.44%12.87B | 1,375.67%8.82B |
| Operating revenue | 0.48%12.79B | 2.66%8.49B | 0.87%4.2B | -0.64%17.37B | -1.12%12.73B | -6.29%8.27B | -0.18%4.16B | 329.51%17.49B | 1,397.44%12.87B | 1,375.67%8.82B |
| Other operating revenue | ---- | 15.79%331.59M | ---- | 16.94%482.72M | ---- | 34.19%286.38M | ---- | 308.92%412.8M | ---- | 2,492.74%213.41M |
| Interest income | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Commission income | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Premiums earned | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Total operating cost | -2.51%11.81B | -1.88%7.8B | -2.81%3.87B | 2.18%16.34B | 4.54%12.11B | 2.44%7.95B | 8.29%3.98B | 313.90%16B | 1,311.48%11.59B | 1,314.22%7.76B |
| Operating cost | -3.00%10.78B | -2.17%7.14B | -3.06%3.56B | 3.70%14.93B | 6.05%11.11B | 4.49%7.3B | 9.55%3.67B | 338.40%14.4B | 1,478.17%10.48B | 1,483.96%6.99B |
| Operating tax surcharges | 34.59%91.07M | 41.30%63.52M | 15.87%27.02M | -31.21%92.3M | -24.33%67.67M | -24.71%44.95M | -15.89%23.32M | 267.85%134.17M | 857.84%89.42M | 791.46%59.7M |
| Operating expense | 7.78%241.03M | 6.18%157.73M | 10.32%77.53M | 20.54%321.12M | 33.41%223.62M | 23.74%148.55M | 15.71%70.28M | 352.16%266.41M | 1,666.01%167.63M | 2,913.54%120.05M |
| Administration expense | 23.76%519.55M | 20.21%313.99M | 17.21%149.54M | -5.98%640.46M | -19.77%419.81M | -23.90%261.21M | -5.46%127.57M | 122.52%681.18M | 526.34%523.26M | 470.33%343.23M |
| Financial expense | -62.98%58.39M | -62.40%38.72M | -65.42%19.23M | -46.99%175.78M | -23.60%157.75M | -35.71%102.99M | -14.08%55.61M | 330.69%331.63M | 2,324.49%206.49M | 3,135.74%160.2M |
| -Interest expense (Financial expense) | -28.97%97.49M | -27.11%72.51M | -35.39%33.37M | -95.39%11.22M | -18.81%137.26M | -31.00%99.48M | -27.67%51.66M | 191.88%243.29M | 1,578.65%169.05M | 2,499.51%144.18M |
| -Interest Income (Financial expense) | 25.47%-8.38M | 24.40%-5.79M | -8.77%-3.26M | 62.64%-4.85M | -13.59%-11.24M | -8.74%-7.66M | -1,000.87%-3M | -193.32%-12.98M | -511.22%-9.9M | -622.32%-7.04M |
| Research and development | -8.92%120.13M | -8.48%80.79M | 11.11%39.01M | -0.52%181.61M | 8.80%131.89M | 0.42%88.28M | -9.11%35.11M | 79.89%182.56M | 163.34%121.22M | 177.79%87.91M |
| Credit Impairment Loss | -61.31%-14.29M | -270.50%-12.67M | -213.83%-15.17M | 48.49%-10.97M | -46.10%-8.86M | 77.95%-3.42M | 36.32%-4.84M | -270.38%-21.31M | -623.51%-6.06M | -572.97%-15.51M |
| Asset Impairment Loss | 9.14%-15.17M | 35.62%-7.42M | 84.47%-1.36M | -43.87%-120.43M | 66.21%-16.7M | 56.88%-11.53M | 17.03%-8.78M | -858.55%-83.71M | -412.14%-49.42M | -261.35%-26.73M |
| Adjustment items of total operating cost | ---- | -200.00%-0.01 | 200.00%0.01 | ---- | ---- | --0.01 | ---0.01 | ---- | ---- | ---- |
| Other net revenue | -7,375.74%-97.37M | -128.53%-44.67M | -4.57%-14.79M | -183.63%-162.11M | 98.37%-1.3M | 53.47%-19.55M | -16.87%-14.14M | -174.10%-57.16M | -402.48%-80M | -283.18%-42.01M |
| Fair value change income | -1,613.62%-91.2M | -50.40%-37.5M | 12.05%-6.9M | -1,958.65%-66.94M | 88.68%-5.32M | -47.72%-24.94M | -188.30%-7.84M | -59.00%3.6M | ---47.03M | ---16.88M |
| Invest income | -87.65%597.64K | -88.50%461.1K | -92.35%240.28K | 157.86%6.52M | 181.63%4.84M | 127.35%4.01M | --3.14M | -10.91%2.53M | -38.62%1.72M | -37.01%1.76M |
| Net open hedge income | ---- | ---- | ---- | --0 | ---- | ---2.54M | ---- | --0 | ---- | ---- |
| -Including: Investment income associates | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Exchange income | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Asset deal income | -143.56%-68.87K | -94.59%61.04K | -98.63%9.96K | -93.20%296.08K | -61.45%158.1K | 227.35%1.13M | 1,318.19%729.37K | 421.37%4.35M | -37.39%410.07K | --344.57K |
| Other revenue | -7.41%22.76M | -30.11%12.4M | 143.55%8.4M | -21.29%29.42M | 20.57%24.58M | 18.23%17.74M | -60.58%3.45M | -9.14%37.38M | 154.91%20.39M | 155.61%15M |
| Adjusted Items effecting operating profit | -200.00%-0.01 | ---- | ---- | ---- | --0.01 | ---- | ---- | ---- | ---- | ---- |
| Operating profit | 43.87%882.79M | 114.51%644.87M | 88.79%313.56M | -39.47%867.35M | -49.08%613.61M | -70.57%300.62M | -65.44%166.09M | 405.21%1.43B | 1,750.03%1.2B | 1,315.53%1.02B |
| Add:Non operating Income | -1.02%11.08M | 225.94%9.48M | 79.81%1.85M | -9.15%12.97M | -8.38%11.19M | -5.04%2.91M | -45.09%1.03M | 257.54%14.28M | 2,415.11%12.22M | 662.55%3.06M |
| Less:Non operating expense | 0.04%13.98M | -33.72%6.14M | 21.02%2.7M | -29.38%16.71M | -17.79%13.98M | -26.49%9.27M | 65.11%2.23M | 152.57%23.66M | 267.51%17M | 199.98%12.61M |
| Add:Adjusted items effecting total profit | ---- | ---- | ---- | ---- | ---- | --0.01 | ---- | ---- | ---- | ---- |
| Total profit | 44.05%879.88M | 120.28%648.2M | 89.65%312.71M | -39.33%863.62M | -49.10%610.82M | -70.93%294.26M | -65.72%164.89M | 411.60%1.42B | 1,867.78%1.2B | 1,380.29%1.01B |
| Less:Income tax cost | 70.97%198.18M | 124.90%138.06M | 38.15%59.22M | -26.04%177.92M | -43.79%115.91M | -65.02%61.39M | -53.08%42.87M | 724.40%240.56M | 5,543.42%206.22M | 4,596.20%175.48M |
| Add:Adjusted items effecting net profit | ---- | ---- | ---0.01 | ---- | --0.01 | ---- | ---- | ---- | ---- | ---- |
| Net profit | 37.74%681.71M | 119.07%510.14M | 107.74%253.49M | -42.04%685.7M | -50.21%494.91M | -72.16%232.87M | -68.69%122.02M | 374.95%1.18B | 1,633.52%993.92M | 1,194.37%836.6M |
| Net profit from continuing operation | 37.74%681.71M | 119.07%510.14M | 107.74%253.49M | -42.04%685.7M | -50.21%494.91M | -72.16%232.87M | -68.69%122.02M | 374.95%1.18B | 1,633.52%993.92M | 1,194.37%836.6M |
| Net income from discontinuing operating | ---- | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | ---- |
| Less:Minority Profit | -18.49%4.49M | 47.08%3.97M | 33.77%2.01M | -98.65%7.74M | -98.88%5.51M | -99.37%2.7M | -99.27%1.5M | 492.83%574.66M | --493.74M | --426.96M |
| Net profit of parent company owners | 38.38%677.22M | 119.91%506.17M | 108.66%251.48M | 11.45%677.95M | -2.16%489.4M | -43.81%230.17M | -34.16%120.52M | 299.85%608.33M | 772.38%500.19M | 533.80%409.65M |
| Earning per share | ||||||||||
| Basic earning per share | 38.36%0.4076 | 120.00%0.3047 | 108.83%0.1514 | -20.34%0.408 | -32.59%0.2946 | -61.30%0.1385 | -54.66%0.0725 | 171.58%0.5122 | 463.14%0.437 | 309.03%0.3579 |
| Diluted earning per share | 38.36%0.4076 | 120.00%0.3047 | 108.83%0.1514 | -20.34%0.408 | -32.59%0.2946 | -61.30%0.1385 | -54.66%0.0725 | 171.58%0.5122 | 463.14%0.437 | 309.03%0.3579 |
| Other composite income | -7.39%19.81M | 2.50%22.73M | 41.58%21.96M | -75.42%2.65M | -1.45%21.39M | 165.74%22.18M | 1,010.19%15.51M | 1,583.39%10.79M | 21.7M | 8.35M |
| Other composite income of parent company owners | -7.39%19.65M | 2.50%22.55M | 41.58%21.78M | -17.29%2.63M | 123.36%21.22M | 502.26%22M | 2,416.07%15.39M | 1,099.10%3.18M | --9.5M | --3.65M |
| Other composite income of minority owners | -7.39%154.51K | 2.50%177.31K | 41.58%171.26K | -99.73%20.69K | -98.63%166.84K | -96.31%172.98K | -84.60%120.96K | 1,960.52%7.61M | --12.2M | --4.69M |
| Total composite income | 35.87%701.52M | 108.93%532.87M | 100.28%275.45M | -42.34%688.35M | -49.16%516.3M | -69.81%255.05M | -64.84%137.53M | 380.69%1.19B | 1,671.37%1.02B | 1,207.28%844.95M |
| Total composite income of parent company owners | 36.48%696.88M | 109.67%528.72M | 101.07%273.27M | 11.30%680.59M | 0.18%510.62M | -38.99%252.17M | -26.00%135.91M | 302.78%611.51M | 788.96%509.69M | 539.45%413.3M |
| Total composite income of minority owners | -18.16%4.64M | 44.40%4.15M | 34.35%2.18M | -98.67%7.76M | -98.88%5.67M | -99.33%2.87M | -99.22%1.62M | 503.22%582.27M | --505.94M | --431.65M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data
